|Articles|July 15, 2004

Imagining the future of pediatrics

What will the pediatrician of 2104 know that we don't know?

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

Contemporary Pediatrics week in review: August 31-September 4, 2026

Contemporary Pediatrics week in review: August 31-September 4, 2026

ByContemporary Pediatrics Staff

September 7th 2026

What to expect in the August/September 2026 issue of Contemporary Pediatrics

ByTina Q. Tan, MD, FAAP, FIDSA, FPIDS

September 7th 2026

Abbott launches first ready-to-feed whole milk infant formula in the U.S. | Image credit: © Abbott

Abbott launches first ready-to-feed whole milk infant formula in the U.S.

ByMorgan Ebert, Executive Editor

September 7th 2026

FDA news in pediatrics: August 2026

FDA news in pediatrics: August 2026

ByMorgan Ebert, Executive Editor

September 4th 2026

The unharmonious 2026 child and adolescent immunization schedule - addendum | Image Credit: © kamon_saejueng

The unharmonious 2026 child and adolescent immunization schedule - addendum

ByJoudeh B. Freij, MD, ScM,Bishara J. Freij, MD

September 4th 2026

Latest CME

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Jordan Axelrad, MD, MPH, FACG, FCCF; Jessica R. Allegretti, MD, MPH; Florian Rieder, MD

Trending on Contemporary Pediatrics

Abbott launches first ready-to-feed whole milk infant formula in the U.S.

FDA news in pediatrics: August 2026

Bifidobacteria Decline: Causes and Consequences for Infant Gut Health

Contemporary Pediatrics week in review: August 31-September 4, 2026

FDA approves zilganersen (Zanvastro) as first treatment for Alexander disease